Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Title:	Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
Authors:	Largeaud, Laetitia^Aff1; Cornillet-Lefebvre, Pascale^Aff2; Hamel, Jean-François^Aff3; Dumas, Pierre-Yves^Aff4; Prade, Naïs^Aff1; Dufrechou, Stéphanie^Aff1; Plenecassagnes, Julien^Aff5; Luquet, Isabelle^Aff1; Blanchet, Odile^Aff6; Banos, Anne^Aff7; Béné, Marie C.^Aff8; Bernard, Marc^Aff9; Bertoli, Sarah^Aff10; Bonmati, Caroline^Aff11; Fornecker, Luc Matthieu^Aff12; Guièze, Romain^Aff13; Haddaoui, Lamya^Aff14; Hunault, Mathilde^Aff15; Ianotto, Jean Christophe^Aff16; Jourdan, Eric^Aff17; Ojeda, Mario^Aff18; Peterlin, Pierre^Aff19; Vey, Norbert^Aff20; Zerazhi, Hacene^Aff21; Yosr, Hicheri^{Aff20, Aff22}; Mineur, Ariane^{Aff23, Aff24}; Cahn, Jean-Yves^Aff25; Ifrah, Norbert^Aff15; Récher, Christian^Aff10; Pigneux, Arnaud^Aff4; Delabesse, Eric^{Aff1, IDs41375020010311_cor31}; Marolleau, J.-P.^Aff26; Aleme, A.^Aff26; Orsini-Piocelle, F.^Aff27; Cadoux, N.^Aff27; Ifrah, N.^Aff28; Hunault, M.^Aff28; Marie, C.^Aff28; Al Jijakli, A.^Aff29; Lepeu, G.^Aff30; Zerazhi, H.^Aff30; Beyrne, M.^Aff30; Banos, A.^Aff31; Labarrere, S.^Aff31; Deconinck, E.^Aff32; Peria, M.^Aff32; El Yamani, A.^Aff33; Kadiri, O.^Aff33; Choufi, B.^Aff34; Brument, M.^Aff34; Pigneux, A.^Aff35; Leguay, T.^Aff35; Dumas, P.-Y.^Aff35; Berthou, C.^Aff36; Guillerm, G.^Aff36; Drugmanne, G.^Aff36; Tournilhac, O.^Aff37; Roy, G.^Aff37; Audhuy, B.^Aff38; Camara, S.^Aff38; Caillot, D.^Aff39; Grandjean, M.^Aff39; Cahn, J.-Y.^Aff40; Bulabois, C.-E.^Aff40; Fief, B.^Aff40; Vey, N.^Aff41; Ladraa, C.^Aff41; Dorvaux, V.^Aff42; Hagopian, M.^Aff42; Fegueux, N.^Aff43; Fenoll, C.^Aff43; Sabadash, V.^Aff43; Ojeda, M.^Aff44; Haby, C.^Aff44; Witz, F.^Aff45; Bonmati, C.^Aff45; Lhuire, M.^Aff45; Delaunay, J.^Aff46; Peterlin, P.^Aff46; Airiau, L.^Aff46; Mannone, L.^Aff47; Touitou, I.^Aff47; Jourdan, E.^Aff48; Umuhire, D.^Aff48; Alexis, M.^Aff49; Michel, O.^Aff49; Dreyfus, F.^Aff50; Bouscary, D.^Aff50; Cheung, A.^Aff50; Sanhes, L.^Aff51; Touhami, F.^Aff51; Ribas, E.^Aff51; Puyade, M.^Aff52; Gallego-Hernanz, M.-P.^Aff52; Hugon, N.^Aff52; Himberlin, C.^Aff53; Maggi, L.^Aff53; Lamy, T.^Aff54; Testu, A.^Aff54; Tavernier, E.^Aff55; Marchand, S.^Aff55; Lioure, B.^Aff56; Kravanja, C.^Aff56; Benboubker, L.^Aff57; Nollet, D.^Aff57; Attal, M.^Aff58; Recher, C.^Aff58; Sarry, A.^Aff58; Lhermitte, A.^Aff59; Yrica, G.^Aff59; Schwartz, D.^Aff59; Le Montagner, N.^Aff59; Fenoll, C.^Aff59; Sabadash, V.^Aff59; Nollet, D.^Aff59; Auvray, L.^Aff59; Delepine, R.^Aff59; Fayault, A.^Aff59
Source:	Leukemia. 35(5):1291-1300
Database:	Springer Nature Journals